We do things in a modern, flexible way. We are not your traditional CRO.
Our success is driven by our innovative approach of working with a globe-wide panel of local, dedicated experts in the field of clinical trials.
The teams we’ve curated share decades of industry experience, and we can proudly say we have unrivalled regional expertise to deliver your study.
We are always striving to help companies reach their innovation potential.
We are nimble and focused on accelerating the discovery, development and delivery of personalised medicine.
The BioTech companies we work with have cutting edge technology in gene therapy, CAR-T cell therapy, CRISPR, immuno-oncology, checkpoint inhibitors and intra-tumoral treatment, just to name a few. Their need to deliver fast, but reliable data is our speciality – we break down barriers and pull out all the stops to get things accomplished in the Biotech world.
Biotechs are not afraid to push the frontiers and do things differently and neither is Momentum Pharma.
We work with major Pharma giants who have a commitment to bring solutions from the petri dish to the patient.
They are focused on discovering and delivering transformational medicines and products in several key therapeutic areas: immunology, oncology, neuroscience, infectious disease and cardiology.
They value embedding Momentum Pharma consultants into their teams, ensuring local expertise, project management and the oversight activities of traditional types of CROs.
There are challenges facing everyone who works in clinical trials, but for early stage companies, navigating these successfully can make or break a pipeline.
From the adoption of technology, to regulatory requirements, vendors and selecting appropriate sites, our experts have you covered.
Our flexibility to provide your start up with agile teams that can be scaled up and scaled down, and incorporate the right team players, will help you avoid the disaster of spiralling costs.
We add a global reach and a local expertise to work with you as trusted partner. Everyone has a role to play in the new era of clinical trials and we embrace and support mutual efforts to get a drug to market and to get treatment options out there.
Momentum Pharma is very proud of the results our team delivers supporting our clients and sponsors in groundbreaking life-saving projects. It is gratifying and motivating to receive recognition for our achievements.
Established
Global Consultants
Sponsors Assisted to Date
Studies Engaged on to Date
Countries Worked in to Date
Momentum Pharma maintains high standards of corporate governance and we strive to stay current in understanding trends and the changing environment within the industry as well as international business. To facilitate this goal, we are active members of a number of organisations and industry groups, some of which are:
Sign up to the Momentum Pharma newsletter “Gaining Momentum” to receive the latest content from Momentum Pharma and highlighted news from the sector.
Our model relies on having connections and relationships with the foremost consultants and service providers in the industry. We don’t rely on hearsay but on the direct experience of working with, or a strong recommendation from our trusted group. Excellence/ proven track record in delivery in the following areas:
Momentum Pharma (Melissa Melton, Jon Melton, Sarah Fritchley) were privileged to attend the amazing IAOCR Industry Leaders Think Tank on Tuesday, 29 April this week. Where to start?! So many inspiring discussions and the sheer ambition and dedication to the clinical trial industry was loud and clear in the room and is
At Momentum, our commitment to giving back remains an integral part of who we are. Each year, our Annual Charity Drive stands as a cherished
The IAOCR Business Process Quality Certification Assesses International Best Practices as Ratified by Industry Experts London and Maidenhead, United Kingdom, 11 December, 2024 – Momentum
As reported in this blog, in June 2024 we were honoured to receive the International Trade Business of the Year Award from the Herefordshire & Worcestershire Chamber
We are thrilled to share some exciting news from Momentum Pharma! On 13 June 2024, we were honoured to receive the prestigious International Trade
Jarmila Yu is an award-winning globally ranked Top100 Chief Marketing Officer, she is a Chartered Marketer and Fellow of both the Institute of Data and Marketing and the Chartered Institute of Marketing. She has over 25 years of experience working with fast paced pioneering IT and professional services companies, ranging from start-ups to blue chips in B2B and B2C.
Jarmila is an entrepreneurial marketing strategist who has a passion for innovation, and a track record for growing and transforming business through efficient, effective, and impactful marketing. Her role as CMO for Momentum Pharma is to ensure the marketing and brand is fit-for-purpose, enabling the company to deliver on its mission to provide the highest calibre of excellence to support its clients in continuing to make medical breakthroughs that improves the quality of life and saves lives.
Cindy is Momentum Pharma’s Administration Manager and joined the company in May 2016 where she performs many roles for the firm. These include corresponding with Sponsors and the Consultants on contractual administration, checking and organising the submission of monthly invoices and expenses of the Consultants. Cindy is the principal controller for the Momentum Pharma Database.
Cindy started her career in 1989 and has a strong Accounting and Finance background. She has worked for Global Financial companies in a number of roles including; Team Leader in the Accounting Department and Account Manager for a large US based client.
Matthew is Momentum Pharma’s Chief Information Officer. He created the bespoke Database and other platforms that the firm uses. Matthew has an engineering and IT background with a broad technical base.
Matthew has worked in the medical device field during his time with a UK engineering company where he programmed the Hardware Control and UI Software design for the NT1000 radio-frequency generator for Thermal Lesioning medical equipment within an ISO 9001:1994 ‘Quality Systems Manufacturing Environment’.
Matthew’s technical skills include electrical and electronic software engineering, systems design and administration. He holds a MSc in Computing and a BEng in Electronic Engineering from Cardiff University of Wales.
Joined Momentum Pharma in September 2022 as the Global Operations Coordinator. Kristina has a degree in Design and Innovation with a strong background in Information Technology.
Building upon her knowledge and experience, Kristina’s role is to facilitate continual development of Momentum’s operations around the world. Working alongside the CEO and COO to implement corporate strategy, assisting with the design, development and implementation of bespoke Momentum systems. Kristina also develops and maintains direct relationships with Momentum’s clients and consultants.
Joined Momentum Pharma in February 2023 as the Operations Administrator. Ellesha’s role is focused on the administrative and operational day-to-day activities of Momentum Pharma.
Ellesha graduated from Harper Adams University with a BSc degree in Animal Behaviour and Welfare and has successfully achieved a Gold Duke of Edinburgh Award in 2015.
Graduated from the University of East Anglia with a BA Honours degree in Business Studies and his professional career began in the Insurance and Reinsurance industry in April 2000.
In 2013, Jon co-founded Momentum Pharma where he holds the role of Chief Operating Officer (COO).
Jon’s career in (Re)Insurance has been wide-ranging in terms of activity and territory. He supported clients and sourced business globally at each stage of his career within the 3 largest global broking houses (Willis, Marsh and Aon).
Jon also has an in-depth experience in Leadership, Project Management and global business transactions.
CEO of Momentum Pharma, possesses over 20 years of clinical research and development experience. During this time, she has worked extensively in the field throughout the US, Canada, UK and Europe (Finland, Sweden, Belgium, Spain, France, Italy and Ireland).
Melissa is a Senior Clinical Trial Consultant which roles include; Clinical Program Manager, Senior CRA, ICH/GCP Quality Assurance Consultant, and CRO Oversight Lead. She has worked for global pharmaceutical giants such as: Roche and J&J, as well as CROs and multiple progressive, cutting-edge Biotech firms.
Her experience is deep in a myriad of therapeutic areas including: adult and paediatric oncology, haematology, cardiovascular, central nervous system, rare genetic disease and more. Melissa has been instrumental in relationship building with key opinion leaders, increasing global program development and risk assessment.
During her expansive career, she has worked on multiple FDA/EMA block buster drugs including the first in class anti-retro viral for HIV (Fuzeon) and numerous life changing Oncology drugs (Avastin, Herceptin, Xeloda and Imbruvica). Melissa holds a BA in Psychology from the University of Arizona. She understands the Sponsor’s needs implicitly, her speciality is strategic plans of action for global development.
Dr. Helen Buck is Momentum’s Consulting Quality and Risk Assessment Manager. She brings to the team 25 years of clinical trials industry expertise and has developed the company’s Standard Operating Procedures (SOP) library, as well as many study plan templates.
Helen has worked on many aspects of clinical trials since starting her Consulting career in 2003 including medical writing and conduct of clinical programmes to ICH GCP guidelines among other roles. Dr. Helen Buck has a PhD in Neuroscience.